Clinical Trials Browser

OTHER × Liver Neoplasms × tislelizumab × Clear all

NCT05532319 2025-12-30

FRONT-1

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06059885 2023-09-29

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms

NCT05339581 2022-04-27

iPLENTY-pvtt

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms